Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Capecitabine 1250, Rectal Cancer, neo-/adjuvant, Part B

Protocol-ID: 422 V1.2 (Mini), CAPE1250, Rectal Ca, neo-/adj., B

Indication(s)

  • Rectal Cancer; ICD-10 C20

Links

  • Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 10/2013 [Therapy algorithm]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 16.02.2023